Monocyte counts are negatively associated with ankle-brachial index values in non-dialysis-dependent chronic kidney

Myung Sung Kim1, Dong-Jin Oh1

  • 1Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea.

Renal Failure
|July 29, 2020
PubMed

Insights

Monocyte counts are linked to lower ankle-brachial index (ABI) values in non-dialysis-dependent chronic kidney disease (NDD-CKD) patients. Higher monocyte levels may indicate a greater risk of peripheral arterial disease in this population.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Chronic kidney disease (CKD) is associated with increased cardiovascular risk.
  • Peripheral arterial disease (PAD), assessed by ankle-brachial index (ABI), is a common complication in CKD patients.
  • Leukocyte subtypes may play a role in the pathogenesis of PAD in CKD.

Purpose of the Study:

  • To investigate the association between leukocyte subtypes and ABI values in patients with non-dialysis-dependent CKD (NDD-CKD).
  • To identify specific leukocyte markers that correlate with reduced ABI, indicating PAD risk.

Main Methods:

  • Cross-sectional study of 79 NDD-CKD patients and 21 controls.
  • ABI measurement using an ABI-form device.
  • Automated analysis of total and differential leukocyte counts.
  • Classification of CKD patients based on estimated glomerular filtration rate (eGFR).

Main Results:

  • Monocyte counts and monocyte-to-total leukocyte count ratio (MTR) were significantly higher in patients with ABI <1.10.
  • Monocyte count (r=-0.341, p=0.044) and MTR (r=-0.346, p=0.031) showed a negative correlation with ABI values.
  • Multivariate analysis confirmed a negative association between monocyte count and ABI (β=-1.825, p=0.013).
  • Monocyte counts demonstrated predictive value for ABI <1.10 (AUC=0.695, p=0.002).

Conclusions:

  • Monocyte count is negatively associated with ABI values in NDD-CKD patients without apparent peripheral arterial occlusive disorder (PAOD).
  • Elevated monocyte levels may serve as a potential biomarker for PAD risk in NDD-CKD.
  • Further research is warranted to explore the mechanistic link between monocytes and PAD in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
427
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
230
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
190
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
246
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
198
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
611